Current usage of long-acting insulin analogs in patients with type 2 diabetes mellitus
Article in Expert Review of Endocrinology & Metabolism (February 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
The Cost-Effectiveness of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review
Article in Value in Health (March 2022)
The Comparative Dosing and Glycemic Control of Intermediate and Long-Acting Insulins in Adult Patients With Type 1 and 2 Diabetes Mellitus
Article in Journal of Pharmacy Technology (November 2021)